https://orcid.org/0000-0002-1528-2739
Reader Comments (1)
Post a new comment on this article
-
0 Responses01 Feb 2021
03:56 GMT
Most RecentAcknowledgements Posted by jkim294 on 01 Feb 2021 at 03:56 GMT
-
Loading metrics
A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia
- Ji Bak Kim,
- Woo Hyuk Song,
- Jong Sung Park,
- Tae-Jin Youn,
- Yong Hyun Park,
- Shin-Jae Kim,
-
Sung Gyun Ahn,
Roles Data curation, Formal analysis, Investigation, Supervision
Affiliation Division of Cardiology, Department of Internal Medicine, Wonju Severance Christian Hospital, Wonju, Korea
⨯ - Joon-Hyung Doh,
- Yun-Hyeong Cho,
-
Jin Won Kim
Roles Funding acquisition, Supervision, Writing – review & editing
* E-mail: kjwmm@korea.ac.kr
Affiliation Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea
⨯
A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia
- Ji Bak Kim,
- Woo Hyuk Song,
- Jong Sung Park,
- Tae-Jin Youn,
- Yong Hyun Park,
- Shin-Jae Kim,
- Sung Gyun Ahn,
- Joon-Hyung Doh,
- Yun-Hyeong Cho,
- Jin Won Kim
x
- Published: January 22, 2021
- https://doi.org/10.1371/journal.pone.0245481